Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Positive    crawled date : 2021 - 04 - 12    save search

Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines
Published: 2021-04-12 (Crawled : 20:00) - biospace.com/
APDN | $0.2888 -12.49% -14.27% 810K twitter stocktwits trandingview |
Commercial Services
| | O: -0.42% H: 10.47% C: -6.22%

covid positive results vaccine trial
APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial
Published: 2021-04-12 (Crawled : 18:00) - adnas.com
APDN | $0.2888 -12.49% -14.27% 810K twitter stocktwits trandingview |
Commercial Services
| | O: -0.42% H: 10.47% C: -6.22%

positive results trial
Bit Digital Announces North American Executive Team Headquartered in New York, Positions for Rapid Growth
Published: 2021-04-12 (Crawled : 13:00) - prnewswire.com
BTBT | $2.205 0.69% 0.68% 7.4M twitter stocktwits trandingview |
Finance
| | O: 2.59% H: 3.28% C: -12.64%

growth positive
Genprex Collaborators Report Positive Preclinical Data for REQORSA™ Immunogene Therapy in Non-Small Cell Lung Cancer at the 2021 AACR Annual Meeting
Published: 2021-04-12 (Crawled : 13:00) - biospace.com/
GNPX | $2.32 7.26% 6.77% 30K twitter stocktwits trandingview |
Health Technology
| | O: 1.57% H: 5.08% C: -6.62%

lung cancer gene therapy positive therapy cancer collaboration preclinical pre-clinical
Kiniksa Announces Positive Results for Mavrilimumab Phase 2 Trial in Non-Mechanically Ventilated Severe COVID-19 Patients
Published: 2021-04-12 (Crawled : 13:00) - biospace.com/
KNSA | $17.66 3.31% 3.2% 610K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.11% C: -8.71%

covid phase 2 positive results positive results trial
Rubius Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of RTX-321 for the Treatment of HPV 16-Positive Cancers
Published: 2021-04-12 (Crawled : 12:15) - globenewswire.com
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: -1.68% H: 2.54% C: -5.2%

treatment phase 1 positive cancer trial rtx-321 phase 3 phase 2
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.